Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Noel M. Bennett"'
Autor:
Timothy D. Henry, Katelyn Storey, Theresa L. Arndt, Christian W. Schmidt, Noel M. Bennett, Jay H. Traverse, Julia Wang, Ross Garberich
Publikováno v:
The American Journal of Cardiology. 129:1-4
Ranolazine is approved for patients with chronic stable angina but has not been formally studied in patients with refractory angina pectoris (RAP). Patients with RAP have limited therapeutic options and significant limitations in their quality of lif
Autor:
Anil K. Poulose, Katelyn Storey, Theresa L. Arndt, Patricia Mitchell, Jay H. Traverse, Ross F. Garberich, Timothy D. Henry, Stephanie Rutten-Ramos, Noel M. Bennett
Publikováno v:
Journal of the Minneapolis Heart Institute Foundation. 2:4-8
As the mortality of coronary artery disease improves and the population ages, an increasing number of patients with refractory angina are not candidates for percutaneous or surgical revascularization. We evaluated the impact of a dedicated refractory
Publikováno v:
Clinical Nuclear Medicine. 39:e355-e358
Diastolic dysfunction is commonly associated with heart failure with preserved systolic function. Diastolic abnormality includes progressively impaired left ventricle (LV) relaxation, followed by pseudonormal mitral inflow pattern with Valsalva enhan
Autor:
Vijay Iyer, Timothy D. Henry, Theresa L. Arndt, Jay H. Traverse, Randall K. Johnson, Annie Lips, Noel M. Bennett, Jill M. Morgan, Anil Poulose, Ross Garberich
Publikováno v:
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 13:96-98
Patients with refractory angina (RA) have limited therapeutic options and significant limitations in their quality of life. Ranolazine is approved for patients with chronic stable angina but has not been studied in patients with RA. The Ranolazine Re
Publikováno v:
Journal of the American College of Cardiology. 71:A1213
As the population ages, an increasing number of patients (pts) will develop refractory angina (RA) from severe myocardial ischemia not amenable for surgical or percutaneous revascularization (PCI). Despite significant limitations in their quality of
Autor:
Jill M. Morgan, Randall K. Johnson, Anil Poulose, Noel M. Bennett, Timothy D. Henry, Vijay Iyer, Jay H. Traverse, Theresa L. Arndt, Ross Garberich
Publikováno v:
Journal of the American College of Cardiology. 57(14)
Autor:
Vijay Iyer, Timothy D. Henry, Jay H. Traverse, Jill M. Morgan, Annie Lips, Rachel E. Olson, Theresa L. Arndt, Ross Garberich, Noel M. Bennett
Publikováno v:
Journal of the American College of Cardiology. 63:A1535
An increasing number of patients (pts) have refractory angina (RA) despite optimal medical management that is not amenable for revascularization. RA pts have a relatively low mortality rate (